United States · FDA National Drug Code directory
Glipizide and Metformin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70518-0373_47f52035-321a-3c7d-e063-6394a90a24ed
- Product NDC
- 70518-0373
- Form
- TABLET, FILM COATED
- Composition / generic term
- Glipizide and Metformin Hydrochloride
- Labeler
- REMEDYREPACK INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170403
- Source listing expiry
- 20271231
Source-listed ingredients
- METFORMIN HYDROCHLORIDE — 500 mg/1
- GLIPIZIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0373-0) · 70518-0373-0
- 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-0373-1) · 70518-0373-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →